Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeStance Health (LFST) Total Liabilities (2020 - 2025)

LifeStance Health (LFST) has disclosed Total Liabilities for 6 consecutive years, with $682.9 million as the latest value for Q4 2025.

  • Quarterly Total Liabilities rose 1.62% to $682.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $682.9 million through Dec 2025, up 1.62% year-over-year, with the annual reading at $682.9 million for FY2025, 1.62% up from the prior year.
  • Total Liabilities for Q4 2025 was $682.9 million at LifeStance Health, up from $656.2 million in the prior quarter.
  • The five-year high for Total Liabilities was $720.0 million in Q3 2023, with the low at -$954.0 million in Q1 2021.
  • Average Total Liabilities over 5 years is $511.2 million, with a median of $655.7 million recorded in 2022.
  • The sharpest move saw Total Liabilities soared 143.59% in 2022, then dropped 6.83% in 2024.
  • Over 5 years, Total Liabilities stood at $382.1 million in 2021, then skyrocketed by 71.47% to $655.1 million in 2022, then grew by 3.95% to $681.0 million in 2023, then decreased by 1.33% to $672.0 million in 2024, then rose by 1.62% to $682.9 million in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $682.9 million, $656.2 million, and $672.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.